ACURA PHARMS (ACUR) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 31 69 sessions, October 1, 2025 to October 6, 2026
- Largest daily move
- +1900% close of March 19, 2026
- 1-year change
- -75% closing prices, October 1, 2025 to October 6, 2026
- 1-month change
- +0% closing prices, September 1, 2026 to October 6, 2026
Company Description
ACURA PHARMS (OTC: ACUR) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $6.7K.
ACUR has declined 75.0% over the past year. The last closing price was $0.0001.
For FY2021, ACURA PHARMS reported revenue of $1.6M with net income of -$879K and diluted earnings per share of -$0.02. The company operates at a net profit margin of -56.2%.
This page collects what Stock Titan holds for ACUR, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
ACURA PHARMS (ACUR) closed at $0.0001 on October 6, 2026. Over the past 12 months, the price has lost 75.0%.
ACUR Metrics & Rankings
Price returns through October 6, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ACURA PHARMS has 9 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all ACUR news →
SEC Filings
ACURA PHARMS has filed 10 recent SEC filings, including 7 Form 8-K, 2 Form NT 10-Q, 1 Form NT 10-K. The most recent filing was submitted on October 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ACUR SEC filings →
Financial Highlights
ACURA PHARMS generated $1.6M in revenue in FY2021, operating income reached -$1.2M (-77.7% operating margin), and net income was -$879K, reflecting a -56.2% net profit margin. Diluted earnings per share stood at -$0.02. The company generated -$742K in operating cash flow. The current ratio was 0.72, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in ACURA PHARMS (ACUR) currently stands at 6.3 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for ACURA PHARMS (ACUR) currently stands at 109.8 days, up 4057.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 6980.6%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
ACUR Company Profile & Sector Positioning
ACURA PHARMS (ACUR) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ACUR often look at related companies in the same sector, including PANACEA LIFE SCIENCE HLD (PLSH), CBD LIFE SCIENCES INC (CBDL), GENIX PHARMACEUTICALS CP (GENPF), ALLIED CORP (ALID), and OVATION SCIENCE INC (OVATF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ACUR's relative position within its industry.